Dreyer Scott 4

4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Feb 12, 2026

AI-generated summary of this filing

Updated Feb 12, 2026

Collegium (COLL) EVP Scott Dreyer Receives Awards; Shares Withheld

What Happened

Scott Dreyer, EVP & Chief Commercial Officer of Collegium Pharmaceutical (COLL), received equity awards on Feb 10, 2026: 19,023 restricted stock units (RSUs) and 30,702 performance share units (PSUs) were recorded as acquired at $0.00 (awards/grants).
To satisfy withholding tax obligations upon vesting, 9,977 shares and 21,615 shares were disposed (code F) at $46.75 per share, generating proceeds shown as $466,425 and $1,010,501 respectively — a total of 31,592 shares withheld and about $1,476,926 in value.
These were award/vesting-related transactions (not open-market purchases or discretionary sales).

Key Details

Transaction date(s): February 10, 2026; Form 4 filed February 12, 2026 (timely — within the usual 2‑business‑day reporting window).
Prices reported: awards at $0.00 (A); tax-withheld share disposals at $46.75 per share (F).
Shares owned after transaction: not disclosed in the provided filing.
Notable footnotes:
- F1: RSUs granted; each RSU converts to one share; one‑third of these RSUs vest Feb 10, 2027, with the remainder vesting annually over the next two years and will be settled in shares.
- F2: 30,702 PSUs were deemed to have met performance-vesting criteria as of Feb 10, 2026.
- F3/F4: The reported disposals reflect shares withheld by the issuer to satisfy applicable withholding taxes upon PSU and RSU vesting (tax-withholding, not market sale).

Context

This is a vesting/award and tax-withholding event: the "disposed" shares are issuer-withheld to cover taxes and do not necessarily indicate a voluntary sale by the insider.
PSUs are performance-based awards; the Compensation Committee determined performance criteria were met for the reported PSUs, triggering vesting.
For retail investors, award vesting is routine compensation-related activity; purchases are typically more informative about insider conviction than tax-withholding dispositions.

Form 4

Period: 2026-02-10

EVP & Chief Commercial Officer

Transactions

Award
Common Stock
[F1]
2026-02-10+19,023→ 122,636 total
Award
Common Stock
[F2]
2026-02-10+30,702→ 153,338 total
Tax Payment
Common Stock
[F3]
2026-02-10$46.75/sh−9,977$466,425→ 143,361 total
Tax Payment
Common Stock
[F4]
2026-02-10$46.75/sh−21,615$1,010,501→ 121,746 total

Footnotes (4)

[F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
[F2]Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 30,702 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
[F3]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
[F4]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.

Signature

/s/ Colleen Tupper as Attorney-In-Fact For Scott Dreyer|2026-02-12

1 file